• Latest Posts
In Depth 19 Jul 2023

Genetic engineering giants: is China poised to lead the way?

New platform cuts time engineering and selecting genome editors

HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor

Five advancements in lupus research over the past year

Eterna acquires allogeneic immuno-oncology platform from Exacis 

ADVERTISEMENT
In Depth 10 Mar 2023

Can CRISPR bring back extinct animals?

Moderna and Life Edit Therapeutics look to speed up gene editing therapies

AI boosts genome editing

Milestone for gene-edited therapy for sickle cell disease

PACT Pharma reports data from CRISPR cancer study

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

ADVERTISEMENT